Ma T - Search Results

1

Pharmacologic modulation of periprosthetic osteolysis.

Goodman SB, Trindade M, Ma T, Genovese M, Smith RL. Goodman SB, et al. Among authors: ma t. Clin Orthop Relat Res. 2005 Jan;(430):39-45. doi: 10.1097/01.blo.0000149998.88218.05. Clin Orthop Relat Res. 2005. PMID: 15662302 Review.

2

Comparison of VEGF-producing cells in periprosthetic osteolysis.

Spanogle JP, Miyanishi K, Ma T, Epstein NJ, Smith RL, Goodman SB. Spanogle JP, et al. Among authors: ma t. Biomaterials. 2006 Jul;27(21):3882-7. doi: 10.1016/j.biomaterials.2006.02.035. Epub 2006 Mar 15. Biomaterials. 2006. PMID: 16540164

3

Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles.

Miyanishi K, Trindade MC, Ma T, Goodman SB, Schurman DJ, Smith RL. Miyanishi K, et al. Among authors: ma t. J Bone Miner Res. 2003 Sep;18(9):1573-83. doi: 10.1359/jbmr.2003.18.9.1573. J Bone Miner Res. 2003. PMID: 12968666 Free article.

4

Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation.

Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL, Goodman SB. Epstein NJ, et al. Among authors: ma t. J Orthop Res. 2005 May;23(3):501-10. doi: 10.1016/j.orthres.2004.10.004. Epub 2005 Jan 19. J Orthop Res. 2005. PMID: 15885468 Free article.

5

Cellular chemotaxis induced by wear particles from joint replacements.

Goodman SB, Ma T. Goodman SB, et al. Among authors: ma t. Biomaterials. 2010 Jul;31(19):5045-50. doi: 10.1016/j.biomaterials.2010.03.046. Epub 2010 Apr 15. Biomaterials. 2010. PMID: 20398931 Free PMC article.

6

Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis.

Ren PG, Irani A, Huang Z, Ma T, Biswal S, Goodman SB. Ren PG, et al. Among authors: ma t. Clin Orthop Relat Res. 2011 Jan;469(1):113-22. doi: 10.1007/s11999-010-1645-5. Clin Orthop Relat Res. 2011. PMID: 21042895 Free PMC article.

7

COX-2 selective inhibitors and bone.

Goodman SB, Ma T, Genovese M, Lane Smith R. Goodman SB, et al. Among authors: ma t. Int J Immunopathol Pharmacol. 2003 Sep-Dec;16(3):201-5. doi: 10.1177/039463200301600303. Int J Immunopathol Pharmacol. 2003. PMID: 14611721 Free article. Review.

8

Effects of local infusion of OP-1 on particle-induced and NSAID-induced inhibition of bone ingrowth in vivo.

Ma T, Nelson ER, Mawatari T, Oh KJ, Larsen DM, Smith RL, Goodman SB. Ma T, et al. J Biomed Mater Res A. 2006 Dec 1;79(3):740-6. doi: 10.1002/jbm.a.30949. J Biomed Mater Res A. 2006. PMID: 16988970

9

Effects of a p38 MAP kinase inhibitor on bone ingrowth and tissue differentiation in rabbit chambers.

Goodman SB, Ma T, Spanogle J, Chiu R, Miyanishi K, Oh K, Plouhar P, Wadsworth S, Smith RL. Goodman SB, et al. Among authors: ma t. J Biomed Mater Res A. 2007 May;81(2):310-6. doi: 10.1002/jbm.a.30983. J Biomed Mater Res A. 2007. PMID: 17120215

10

Efficacy of a p38 mitogen activated protein kinase inhibitor in mitigating an established inflammatory reaction to polyethylene particles in vivo.

Ma T, Ren PG, Larsen DM, Suenaga E, Zilber S, Genovese M, Smith RL, Goodman SB. Ma T, et al. J Biomed Mater Res A. 2009 Apr;89(1):117-23. doi: 10.1002/jbm.a.31957. J Biomed Mater Res A. 2009. PMID: 18431764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,379 results

Search Page

Filters